Ethyl Acetate Fraction of the Root of Rubia cordifolia L. Inhibits Keratinocyte Proliferation In Vitro and Promotes Keratinocyte Differentiation In Vivo: Potential Application for Psoriasis Treatment
机构:[1]School of Chinese Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China[2]School of Pharmacy, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China[3]School of Biomedical Sciences, Department of Biochemistry, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China[4]Department of Dermatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China大德路总院皮肤科大德路总院皮肤科广东省中医院[5]School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China
Psoriasis is a skin disease associated with hyperproliferation and aberrant differentiation of keratinocytes. Our previous studies have identified the root of Rubia cordifolia L. as a potent antiproliferative and apoptogenic agent in cultured HaCaT cells (IC(50) 1.4 mu g/ml). In the present study, ethanolic extract of Radix Rubiae was fractioned sequentially with hexane, ethyl acetate (EA), n-butanol and water. EA fraction was found to possess most potent antiproliferative action on HaCaT cells (IC(50) 0.9 mu g/ml. Mechanistic study revealed that EA fraction induced apoptosis on HaCaT cells, as it was capable of inducing apoptotic morphological changes. Annexin V-PI staining assay also demonstrated that EA fraction significantly augmented HaCaT apoptosis. In addition, EA fraction decreased mitochondrial membrane potential in a concentration- and time-dependent manner. The standardized EA fraction was formulated into topical gel and its keratinocyte-modulating action was tested on mouse tail model. EA fraction dose-dependently increased the number and thickness of granular layer and epidermal thickness on mouse tail skin, indicative of the keratinocyte differentiation-inducing activity. Taking the in vitro and in vivo findings together, the present preclinical study confirms that EA fraction is a promising antipsoriatic agent warranting further development for psoriasis treatment. Copyright (C) 2009 John Wiley & Sons, Ltd.
基金:
Innovation Technology Fund of Hong Kong [GHP/021/06]; Chinese University of Hong KongChinese University of Hong Kong [2030363]
第一作者机构:[1]School of Chinese Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China[*1]School of Chinese Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China
通讯作者:
通讯机构:[1]School of Chinese Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China[3]School of Biomedical Sciences, Department of Biochemistry, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China[*1]School of Chinese Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China[*2]School of Biomedical Sciences, Department of Biochemistry, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China
推荐引用方式(GB/T 7714):
Z. X. Lin,B. W. Jiao,C. T. Che,et al.Ethyl Acetate Fraction of the Root of Rubia cordifolia L. Inhibits Keratinocyte Proliferation In Vitro and Promotes Keratinocyte Differentiation In Vivo: Potential Application for Psoriasis Treatment[J].PHYTOTHERAPY RESEARCH.2010,24(7):1056-1064.doi:10.1002/ptr.3079.
APA:
Z. X. Lin,B. W. Jiao,C. T. Che,Z. Zuo,C. F. Mok...&C. H. K. Cheng.(2010).Ethyl Acetate Fraction of the Root of Rubia cordifolia L. Inhibits Keratinocyte Proliferation In Vitro and Promotes Keratinocyte Differentiation In Vivo: Potential Application for Psoriasis Treatment.PHYTOTHERAPY RESEARCH,24,(7)
MLA:
Z. X. Lin,et al."Ethyl Acetate Fraction of the Root of Rubia cordifolia L. Inhibits Keratinocyte Proliferation In Vitro and Promotes Keratinocyte Differentiation In Vivo: Potential Application for Psoriasis Treatment".PHYTOTHERAPY RESEARCH 24..7(2010):1056-1064